These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2868929)

  • 1. [Role of dopaminergic systems of the neostriatum in processes of higher nervous activity in animals and man].
    Suvorov NF; Volynkina GIu
    Fiziol Zh SSSR Im I M Sechenova; 1986 Jan; 72(1):48-55. PubMed ID: 2868929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronology of the extrapyramidal effects of neuroleptics, and the nigrostriatal dopaminergic system].
    Petit M; Lepine JP; Lesieur P
    Encephale; 1979; 5(4):297-316. PubMed ID: 42527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The striatonigral dopaminergic system and its role in adaptive conditioned reflex behavior].
    Suvorov NF; Iakimovskiĭ AF; Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1984 May; 70(5):594-600. PubMed ID: 6468694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopamine metabolism and the GABA level in the structures of the nigrostriatal and mesolimbic systems of the rat brain in experimental pathology of higher nervous activity].
    Saul'skaia NB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(6):1145-51. PubMed ID: 3245325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopamine concentration in the nigro-striatal system during elaboration and performance of conditioned avoidance reactions of various complexity in rats].
    Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1981 Jun; 67(6):797-803. PubMed ID: 7274479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of damage to the substantia nigra on conditioned reflex activity in animals].
    Gambarian LS; Sarkisian ZhS; Garibian AA; Koval' IN; Madatova IR
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1981; 31(6):1247-54. PubMed ID: 7331509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intracerebral transplantation of immature substantia nigra in rats with experimentally induced Parkinson's disease. III. Results of behavioural and biochemical investigations.
    Dymecki J; Puciłowski O; Dyr W; Markiewicz D; Półtorak M; Kostowski W; Hauptmann M; Lipińska B
    Neuropatol Pol; 1985; 23(3):287-95. PubMed ID: 4088461
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dopamine metabolism in structures of the striato-nigral system during elaboration of conditioned avoidance reflexes in rats].
    Saul'skaia NB; Chivileva OG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1981; 31(5):1083-5. PubMed ID: 6797145
    [No Abstract]   [Full Text] [Related]  

  • 9. [Participation of rat cerebral dopaminergic structures in the process of reproducing conditioned passive avoidance reactions].
    Spiridonov VK
    Neirofiziologiia; 1976; 8(2):209-11. PubMed ID: 1272468
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopaminergic activation of Fos and the rat model of Parkinson's disease.
    Cole DG
    Adv Neurol; 1993; 60():334-7. PubMed ID: 8380526
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the nigrostriatal dopaminergic neurons in mediating the effect of exogenous L-dopa in Parkinson's disease.
    Melamed E
    Mt Sinai J Med; 1988 Jan; 55(1):35-42. PubMed ID: 3279303
    [No Abstract]   [Full Text] [Related]  

  • 12. The dopaminergic nigrostriatal system: development, physiology, disease.
    von Bohlen Und Halbach O; Krieglstein K; Schober A; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):3. PubMed ID: 15340830
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
    Duteil J; de Sereville JE; Multon MF; Pessonnier J; Rambert FA
    Ann Pharm Fr; 1987; 45(1):25-34. PubMed ID: 3662339
    [No Abstract]   [Full Text] [Related]  

  • 15. [Level of dopamine in structures of the nigro-striatal and mesolimbic systems of the brain in experimental pathology of higher nervous activity in the rat].
    Saul'skaia NB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(3):561-4. PubMed ID: 4041098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
    Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
    Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions.
    Scheel-Krüger J
    Adv Neurol; 1984; 40():85-90. PubMed ID: 6141713
    [No Abstract]   [Full Text] [Related]  

  • 18. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
    Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Avoidance reaction in rats following dopamine administration to the neostriatum].
    Iakimovskiĭ AF
    Fiziol Zh SSSR Im I M Sechenova; 1980 Sep; 66(9):1312-8. PubMed ID: 7418912
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of functional heterogeneity of rat forebrain dopamine-reactive structures].
    Iakimovskiĭ AF
    Fiziol Zh SSSR Im I M Sechenova; 1981 Sep; 67(9):1317-23. PubMed ID: 7297728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.